Ayurvedic study of Herbal drug tablet in overweight and high Cholesterol level persons to reduce the weight and blood Cholesterol level.

A Randomized Control Study to Evaluate Effectiveness of Bilwadi Panchmool Ghana Vati in Comparison to Fenofibrate in Management of Increased Triglyceride Levels - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107472

Enrollment

100

Registered

2026-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E668- Other obesity

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed patients of sthoulya or medoroga or kapha vrudhi and increased Triglyceride levels (after fasting for 10hrs) from OPD & IPD. 2. Suitable case paper Performa will be designed for the study. 3.100 patients of increased triglyceride levels (Can be Compare with Kaphavrudhi or medorog or hypertriglyceridemia) will be selected randomly 50 for each group. 4. Medicine will be repeated every 15 days after follow up upto 90 days. Patients will be selected on the basis of Lipid profile reports. 4. Patients having increased Triglycerides level more than 150 mg per dL.

Exclusion criteria

Exclusion criteria: 1. The patients below 18 yrs. And above 55 yrs will be not be included. 2. patients suffering from major diseases like medasara, mansara and pregnant women will not be selected.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of BilwadiPanchmool Ghana Vati with Fenofibrate in reducing triglyceride levels (after fasting for 10 hrs).Timepoint: 0th Day (Baseline Assessment) , 15th Day (Follow Up ) for 3 month	—

Secondary

Measure	Time frame
1) To compare the effect of BilwadiPanchamool Ghana vati on triglyceride levels with the effect of fenofibrate . 2) To compare the effect of BilwadiPanchamoolghanavati and fenofibrate on Lipid Profile ( Cholesterol, HDL , LDL levels) Timepoint: 0th Day (Baseline Assessment ) Follow up will be taken at an interval of 15 days for 3 months.	—

Countries

India

Contacts

Public ContactPushkaraj Shrikant Kulkarni

Faculty of Indian Medical System , SGT University Gurgaon.

anilherbals@gmail.com9416085092

Outcome results